In the latest trading session,, 1.48 million Revelation Biosciences Inc (NASDAQ:REVB) shares changed hands as the company’s beta touched -0.32. With the company’s most recent per share price at $2.99 changed hands at -$0.7 or -18.97% at last look, the market valuation stands at $2.71M. REVB’s current price is a discount, trading about -1933.44% off its 52-week high of $60.80. The share price had its 52-week low at $2.36, which suggests the last value was 21.07% up since then. When we look at Revelation Biosciences Inc’s average trading volume, we note the 10-day average is 61050.0 shares, with the 3-month average coming to 130.01K.
Analysts gave the Revelation Biosciences Inc (REVB) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended REVB as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight. Revelation Biosciences Inc’s EPS for the current quarter is expected to be -6.88.
Revelation Biosciences Inc (NASDAQ:REVB) trade information
Instantly REVB was in red as seen in intraday trades today. With action 11.99%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -59.46%, with the 5-day performance at 11.99% in the green. However, in the 30-day time frame, Revelation Biosciences Inc (NASDAQ:REVB) is -10.48% down. Looking at the short shares, we see there were 23472.0 shares sold at short interest cover period of 0.36 days.
Revelation Biosciences Inc (REVB) estimates and forecasts
According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.00%. The estimates for the next quarter sales put growth at 0.00%. The 2025 estimates are for Revelation Biosciences Inc earnings to increase by 75.25%, but the outlook for the next 5-year period is at 68.43% per year.
Revelation Biosciences Inc (NASDAQ:REVB)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 5.09% of Revelation Biosciences Inc shares while 6.81% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 7.17%.
Among Mutual Funds, the top two as of Feb 28, 2025 were Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund . With 501.0 shares estimated at $1503.0 under it, the former controlled 0.06% of total outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund held about 0.04% of the shares, roughly 363.0 shares worth around $1089.0.
